Kamat Pharmatech is a New Jersey, USA–based pharmaceutical development company focused on advancing science through strategic formulation, regulatory expertise, and commercialization support.
With a commitment to quality and innovation, we partner with clients to develop complex generics, injectable and lyophilized formulations, and innovative oral liquids and topical products.
Kamat Pharmatech is a pharmaceutical contract development organization (CDO) located in North Brunswick, NJ, USA for over twelve (12) years, specializing in complex injectables (lyophiles, suspensions, liposomes, emulsions, and microspheres), topicals, ophthalmics, and unique oral liquid products.
Kamat Pharmatech assists companies around the world in R&D projects of sterile and other non-solid dosage form products — formulation, process development, Lyo product/process, QbD, Complex injectables, and IVRT characterization. Its laboratories can handle potent, cytotoxic, and hazardous substances, as well as Controlled Drugs (CII to CIV).
With many products in the development phases which include complex injectables, 505(B)(2) opportunities, ophthalmics, and topical products; the company is an ideal partner for collaboration due to its vast experience in the development field, familiarity with the US-FDA, networking capability in the regulatory world, and the reputation within the industry.
Kamat Pharmatech is headed by Dr. Madhav Kamat, Ph.D., R.Ph., with over 42 years of experience in the pharmaceutical industry in the USA, and a management team with a track record of developing many major commercial products including more than ten (10) biologicals in the US and other regulated markets.
Dr. Kamat has been also an avid educator/trainer in the field of parenteral sciences — especially lyophilization — and offers regular training courses to institutions worldwide.
Kamat Pharmatech has a deep potential pipeline of many products — complex injectables, topicals, and oral liquid products.
Our primary and the only mission is to assist our clients in the development of unique, medically necessary, and technologically innovative products — for us and for our customers, with the highest commitment to science, technology, and integrity.
Chief Executive Officer, Kamat Pharmatech. Dr. Kamat founded Kamat Pharmatech in 2013 after 27 years in highly technical roles at companies such as Centocor, J&J, and Bristol Myers Squibb.
Recognized expert in lyophilization, nano-suspension technology, aseptic technology, and other sterile manufacturing processes. Selected products involved in development/launch/support:
Registered pharmacist in New Jersey and Pennsylvania. Course director for “Lyophilization Technology” in the US, Europe, and worldwide.
LinkedIn: View profile
Kamat Pharma specializes in pharmaceutical development with a focus on advanced formulations and regulatory strategies. Our key service areas include:
We partner with clients to bring high-quality pharmaceutical products to market through proven expertise and customized solutions.
Email: mk@kamatpharma.com
Phone: (___) ___-____
Webmaster: Form is temporarily offline — please email mk@kamatpharma.com.